Search clinical trials for: BPX-01 2% Minocycline Topical Gel

Total 47 results

BioPharmX, Inc.

Completed

BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris (OPAL)

Acne Vulgaris

United States
BioPharmX, Inc.

Completed

Open Label Phase 2 Feasibility Study of BPX-04 Topical Minocycline Gel in Rosacea

Moderate to Severe Papulopustular Rosacea

United States
BioPharmX, Inc.

Completed

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

Acne Vulgaris

United States
Hovione Scientia Limited

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea

Rosacea | Papulopustular Rosacea

United States
BioPharmX, Inc.

Unknown

Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea (PRISM)

Papulopustular Rosacea

United States
BioPharmX, Inc.

Completed

Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel

Acne Vulgaris

United States
Novan, Inc.

Completed

Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers

Acne Vulgaris

United States
Sol-Gel Technologies, Ltd.

Terminated

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Basal Cell Nevus Syndrome

United States, France, Belgium, Denmark, Germany, Italy, Netherlands, Spain, United Kingdom
Riphah International University

Completed

Comparing the Efficacy of Metronidazole and Minocycline Gels for the Treatment of Diabetic Periodontitis Patients

Diabetes Mellitus | Periodontitis

Pakistan
Hoth Therapeutics, Inc.
Worldwide Clinical Trials

Recruiting

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors (CLEER)

Acneiform Eruption Due to Chemical | Xerosis Cutis | Paronychia

United States
Riyadh Elm University

Unknown

Locally Delivered Antibiotics for the Treatment of Periodontitis

Periodontitis
Sol-Gel Technologies, Ltd.

Terminated

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Recurrent Basal Cell Carcinoma

United States
Badr University

Completed

Tackling Pressure Ulcer Via Bee Venom Phonophoresis (ulcer)

Pressure Ulcers | Phonophoresis | Bee Venom

Egypt
PellePharm, Inc.

Completed

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

Basal Cell Nevus Syndrome

United States, Spain, Germany, United Kingdom, Italy, France, Belgium, Canada, Denmark, Netherlands
Taro Pharmaceuticals USA

Completed

Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis

Tinea Pedis
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Pleural Abrasion Plus Minocycline Versus Apical Pleurectomy for Primary Spontaneous Pneumothorax

Pneumothorax

Taiwan
TWi Biotechnology, Inc.

Recruiting

Study to Evaluate the Safety and Tolerability of AC-1101 Topical Gel in Patients With Granuloma Annulare

Granuloma Annulare

United States
Destiny Pharma Plc

Completed

Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects

Staphylococcus Aureus Infection

United Kingdom
Padagis LLC

Completed

Comparative Safety and Efficacy of Two Rosacea Products in the Treatment of Facial Erythema of Rosacea

Rosacea
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Acne Vulgaris

United States
Wake Forest University Health Sciences

Completed

Internet Surveys and Their Impact on Adherence for Rosacea

Rosacea

United States
Universiteit Antwerpen
KU Leuven; Amsterdam UMC, location VUmc; Vrije Universiteit Brussel; Research Foundation...

Not yet recruiting

INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder (INSTA-MD)

Inflammation | Major Depressive Disorder

Belgium
Second Affiliated Hospital, School of Medicine,...

Unknown

Corneal Protect Used During Cataract Surgery (CPUDCS)

Cataract

China
BioDelivery Sciences International

Completed

The Efficacy and Safety of Clonidine Hydrochloride Topical Gel, vs Clonidine Hydrochloride Gel Comparator to Treat Painful Diabetic Neuropathy

Neuropathy | Painful Diabetic Neuropathy | Diabetic Neuropathy

United States
University of Southern California
Solvay Pharmaceuticals

Completed

Effects of Testosterone Gel on Carbohydrate and Lipid Metabolism In Elderly Obese Men

Obesity | Insulin Resistance | Aging | Hypogonadism

United States
Arcion Therapeutics Inc

Completed

Efficacy and Safety Study of ARC-4558 for Management of Pain Associated With Painful Diabetic Neuropathy

Painful Diabetic Neuropathy

United States
Universidade do Vale do Sapucai

Completed

Acmella Oleracea in the Analgesia of the Digital Rectal Examination

Analgesia in the Digital Rectal Examination

Brazil
Skin Laser & Surgery Specialists
Galderma R&D

Terminated

Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea

Erythema and Flushing Associated With Rosacea
Research Institute of Ophthalmology, Egypt

Completed

Lidocaine Gel 2% and Muscle Traction Pain During Squint Surgery in Pediatrics

Squint

Egypt
Mallinckrodt

Completed

Pharmacokinetics, Bioavailability and Safety of PENNSAID® Gel

Pain

United States
BioDelivery Sciences International

Completed

A Safety Study of Clonidine Hydrochloride Topical Gel, 0.1% in the Treatment of Painful Diabetic Neuropathy

Diabetes | Painful Diabetic Neuropathy

United States
ASTORA Women's Health

Completed

Pelvic Floor Repair Systems for Prolapse Repair (PROPEL)

Pelvic Organ Prolapse

United States, Belgium, France, Germany, Netherlands, Spain, United Kingdom
Children's Hospital of Philadelphia
Society for Pediatric Dermatology

Withdrawn

Timolol Option for Ulcerated Hemangiomas (TOUCH Trial) (TOUCH)

Infantile Hemangiomas

United States
Boston University

Withdrawn

Effectiveness of Synapse Transcutaneous Electronic Nerve Stimulation (TENS) During Dental Procedures Among Children

Anesthesia, Local | Pediatric Dentistry | Dental Fear

United States
British Columbia Cancer Agency
Hoffmann-La Roche

Completed

Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer (LUTRAERL)

Rash

Canada
Joanneum Research Forschungsgesellschaft mbH

Completed

Evaluate the Ability of dOFM for BE Testing of Topically Applied Diclofenac Sodium Products in Healthy Subjects

Healthy

Austria
Retina Vitreous Associates of Florida

Completed

Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival

Age-related Macular Degeneration | Central Retinal Vein Occlusion | Diabetic Macular Edema

United States
ARKAY Therapeutics
Albany Medical College

Not yet recruiting

Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients (RESILIENCE)

Obesity | Arthritis | Type 2 Diabetes | High Blood Pressure

United States
Medstar Health Research Institute

Recruiting

Local Anesthesia Before Bulkamid Injection (LAB)

Stress Urinary Incontinence | Intrinsic Sphincter Deficiency

United States
Zagazig University

Completed

Effect of Palatable Lidocaine Gel on Gag Reflex for Patients Undergoing Upper Gastrointestinal Endoscopy

Gastro-Intestinal Disorder

Egypt
Ataturk University

Unknown

Ultrasound-Guided Erector Spinae Plan Block in Patients Undergoing ESWL

Pain | Urinary System Stones

Turkey
British Columbia Cancer Agency

Completed

Neuropathic Pain Caused by Radiation Therapy (NP)

Neuropathic Pain Secondary to Radiation Therapy

Canada
GlaxoSmithKline

Completed

Study to Evaluate the Pharmacokinetic Profile of Salbutamol Delivered by Unit Dose Dry Powder Inhaler (UD-DPI) Compared to the Diskus and Metered Dose Inhaler (MDI) in Healthy Volunteers.

Asthma

Australia
National Cancer Institute (NCI)

Not yet recruiting

Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm
Fred Hutchinson Cancer Center
Nektar Therapeutics

Recruiting

NKTR-255 in Combination With CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Large B-cell Lymphoma

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Recurrent Grade 3b Follicular Lymphoma | Refractory Grade 3b Follicular... and other conditions

United States
OHSU Knight Cancer Institute
Genentech, Inc.; Oregon Health and Science University

Withdrawn

SMMART Adaptive Clinical Treatment (ACT) Trial

Anatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditions

United States
National Cancer Institute (NCI)

Active, not recruiting

Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)

Glioma | Hematopoietic and Lymphoid Cell Neoplasm | Melanoma | Lymphoma | Multiple Myeloma | Recurrent Ovarian Carcinoma | Breast Carcinoma | Recurrent Head and Neck Carcinoma | Recurrent Lung Carcinoma | Recurrent Skin Carcinoma | Gastric Carcinoma | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory... and other conditions

United States, Puerto Rico, Guam

Search clinical trials for: BPX-01 2% Minocycline Topical Gel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations